Skip to content

UEL Research Conference: Session 8 Stimulating and Regulating New Markets

Vassilis-FouskasInternational Politics & Economics: A Research Agenda for STAMP
Vassilis Fouskas, Royal Docks Business School‌‌‌‌‌‌‌‌‌

The Centre for the Study of States, Markets & People (STAMP) is an inter-disciplinary concentration of scholars mainly from the field of international relations, political economy and social sciences. Although based in the Royal Docks Business School of UEL, its members are drawn from across UEL and other institutions and agencies in the country and abroad. But what is STAMP’s actual research agenda and how does it plan to involve broader social actors in its activities? How can STAMP raise its national and international profile? These are some of the question this talk will attempt to address. Download the full abstract. 

Steven EastwoodCinemautism: provisional and super knowledge in the (rooms and) social space of cinema
Steven Eastwood, School of Arts and Digital Industries ‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌

People with autism have said that the world, to them, is a mass of people, places and events, which they struggle to make sense of, and which can cause them considerable anxiety. There are apparent parallels to be drawn with the systems of narrative cinematic arrangements. Much like the “other people” described by those with autism, the normative cinema appears to know, intuitively, how to communicate and interact with the other of the audience. It knows what to reveal, what to conceal, where and how to be. But when and how might the much debated screen-mind relationship produce a frustration of otherness, or tamper with an audience’s ability to ascribe provisional knowledge to others? Download the full abstract.

Mike-SeedThe accidental discovery of a new drug series for treating rheumatoid arthritis, an international effort
Michael Seed, School of Health, Sport and Bioscience‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌

Rheumatoid arthritis is an autoimmune disease affecting 1% of the population, causing profound pain and disability, and leading to an early death. 40% of patients are unresponsive to the revolutionary new treatments, which are also expensive and require injections.

UEL, researchers are investigating promising insights into how the new drug Diosamine octasulphate (DOS)  may work, the next step in developing a new medication for arthritis. Download the full abstract

Go to session 9 Early Life


No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: